Alan Remaley serves as a Medical Officer in the Public Health Service at the National Institutes of Health. He received his B.S. degree in biochemistry and chemistry from the University of Pittsburgh in 1981. He received the M.D. and Ph.D. (in biochemistry) degree from the same university. He completed in 1990 a residency in clinical pathology at the University of Pennsylvania and became board certified in clinical pathology in 1992. He joined the National Institutes of Health in 1990, as a Medical Staff Fellow, and did a postdoctoral fellowship on lipoprotein metabolism at the Molecular Disease Branch of the National Heart, Lung, and Blood Institute. He became in 1995 a Senior Staff Member at the Department of Laboratory Medicine, the National Institutes of Health, where he directs the Immunoassay and HPLC/Mass Spectrometry laboratories. In 2005, he became the Section Chief of the Lipoprotein Metabolism Laboratory at NHLBI. His current research focuses on the mechanism of action of the ABCA1 transporter and its role in HDL metabolism. In addition, he is involved in developing new diagnostic immunoassays and lipoprotein assays. He (co)authored over 150 publications, mostly in the fields of lipoprotein metabolism and clinical pathology, and holds four patents. He is a Member of the editorial boards of many journals and of several associations and societies.
Biography Updated on 5 December 2011